← Back to Search

Nicotine Concentration: Low; Nicotine Source Claim 3 for Risky Behaviors

N/A
Recruiting
Led By Darren Mays, MPH, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up single time point for 25 minutes
Awards & highlights

Study Summary

This trial aims to understand what young adults who are at risk of using tobacco/nicotine products but do not currently use them, as well as adults who do use these products, know and think about

Who is the study for?
This trial is for adults aged 18-65 who either use tobacco products or are young adults (18-24) at risk of starting. Tobacco users must have used combustible, non-combustible, or both types of tobacco regularly for the past 6 months. Non-users should be open to using tobacco but haven't started yet. All participants must be able to visit the lab in person.Check my eligibility
What is being tested?
The study is examining how claims about nicotine products influence their appeal and perceptions among young adult non-users susceptible to smoking and adult smokers. It's a controlled experiment where participants are exposed to different product claims in a lab setting.See study design
What are the potential side effects?
Since this is an observational study focusing on perceptions and behaviors rather than testing a medical intervention, there aren't direct side effects from treatments like you'd expect with drug trials.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~single time point for 25 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and single time point for 25 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Arousal
Cognitive Attention
ONP Intentions
+6 more
Other outcome measures
ONP Trial (Lapse Task)

Trial Design

9Treatment groups
Experimental Treatment
Group I: Nicotine Concentration: None Displayed; Nicotine Source Claim 3Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Group II: Nicotine Concentration: None Displayed; Nicotine Source Claim 2Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Group III: Nicotine Concentration: None Displayed; Nicotine Source Claim 1Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Group IV: Nicotine Concentration: Low; Nicotine Source Claim 3Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Group V: Nicotine Concentration: Low; Nicotine Source Claim 2Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Group VI: Nicotine Concentration: Low; Nicotine Source Claim 1Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Group VII: Nicotine Concentration: High; Nicotine Source Claim 3Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Group VIII: Nicotine Concentration: High; Nicotine Source Claim 2Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.
Group IX: Nicotine Concentration: High; Nicotine Source Claim 1Experimental Treatment1 Intervention
Participants view randomized images of nicotine-containing product packaging and complete a lapse task test on study. Participants also complete questionnaires on study.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,672 Previous Clinical Trials
40,925,991 Total Patients Enrolled
Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
289,645 Total Patients Enrolled
Darren Mays, MPH, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to participate in this ongoing medical study?

"To be eligible for participation in this research, individuals must engage in behaviors that carry inherent risk and fall within the age range of 18 to 65 years old. The trial has a capacity to accommodate approximately 450 participants."

Answered by AI

Can individuals who are below the age of 40 be considered as potential participants for this research study?

"To be eligible for participation in this clinical trial, individuals must fall within the age range of 18 to 65. It is worth noting that there are separate trials available specifically for patients under the age of 18 (4 trials) and those over the age of 65 (3 trials)."

Answered by AI

Are individuals still being accepted for participation in this ongoing medical study?

"According to the data provided on clinicaltrials.gov, this specific clinical trial is not currently seeking candidates. The trial was originally posted on January 14th, 2024 and was last updated on January 3rd, 2024. However, there are eight other trials presently accepting patients for participation."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior
Darren Mays 2024. "Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06192316.
~300 spots leftby Sep 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top